Krzysztof Palczewski

From Wikipedia, the free encyclopedia

Krzysztof Palczewski, Ph.D is a Polish biochemist.

His MS and PhD are from the University of Wroclaw and Technical University of Wroclaw respectively (Poland), working with Dr. M. Kochman. His early posts were at the University of Florida and the Oregon Health Sciences University. Dr. Palczewski completed much of his pivotal research at the University of Washington and moved to become the Chair and John H. Hord professor of Pharmacology at Case Western Reserve University in 2005.^[1]

He is the founder of two drug discovery companies, Polgenix and Retinagenix.^[2]

Research interests

Palczewski's research interest lie in mapping the Visual Transduction System. His work with determining the crystal structure of rhodopsin has given new insight into the function of G protein receptors. This work has led to revolutionary advances in understanding hereditary blindness and can slow retinal degeneration in adults.

References

Notes

Bibliography

Vertebrate Phototransduction and the Visual Cycle, Krzysztof Palczewski, Academic Press (2000), ISBN 0-12-182217-6

External links

Persondata
Name	Palczewski, Krzysztof
Alternative names
Short description
Date of birth
Place of birth
Date of death
Place of death

This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.